Evaxion Publishes Data, Showing 67 percent Objective Response Rate in Metastatic Melanoma for the AI-Designed Personalized Cancer Vaccine EVX-01, in Leading Medical Journal
| EVAX Stock | USD 1.30 0.01 0.78% |
Slightly above 61% of Evaxion Biotech's investor base is looking to short. The analysis of the overall investor sentiment regarding Evaxion Biotech AS suggests that many traders are alarmed. Evaxion Biotech's investing sentiment can be driven by a variety of factors including economic data, Evaxion Biotech's earnings reports, geopolitical events, and overall market trends.
Evaxion |
A 67 percent objective response rate is reported in the publication summarizing results from the Phase 1 study assessing Evaxions personalized cancer vaccine, EVX-01, in patients with metastatic melanoma The findings also demonstrate strong and clinically relevant immune responses after EVX-01 administration to metastatic melanoma patients co-treated with anti-PD-1 standard of careThe clinical study results substantiate the precision and predictive power of Evaxions AI-Immunology platform Evax
Read at finance.yahoo.com
 |
Evaxion Biotech Fundamental Analysis
We analyze Evaxion Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Evaxion Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Evaxion Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
Evaxion Biotech is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Evaxion Biotech AS Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Evaxion Biotech stock to make a market-neutral strategy. Peer analysis of Evaxion Biotech could also be used in its relative valuation, which is a method of valuing Evaxion Biotech by comparing valuation metrics with similar companies.
Peers
Evaxion Biotech Related Equities
| RVPH | Reviva Pharmaceuticals | 18.87 | ||||
| UNCY | Unicycive Therapeutics | 9.59 | ||||
| QNRX | Quoin Pharmaceuticals | 5.48 | ||||
| ALLR | Allarity Therapeutics | 2.94 | ||||
| ZURA | Zura Bio | 0.72 | ||||
| CGEM | Cullinan Oncology | 0.24 | ||||
| ZVSA | ZyVersa Therapeutics | 1.75 | ||||
| RVMD | Revolution Medicines | 1.82 | ||||
| PHIO | Phio Pharmaceuticals | 3.91 | ||||
| BDRX | Biodexa Pharmaceticals | 4.91 | ||||
| VRAX | Virax Biolabs | 6.08 | ||||
| RNAZ | Transcode Therapeutics | 6.63 | ||||
| REVB | Revelation Biosciences | 6.67 | ||||
| LYEL | Lyell Immunopharma | 7.61 | ||||
| GLUE | Monte Rosa | 9.85 |
Additional Tools for Evaxion Stock Analysis
When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.